We are live on ! Find out more
QC

Quadrature Capital Portfolio holdings

AUM $11.7B
1-Year Est. Return 87.29%
This Fund
S&P 500
This Quarter Est. Return
+5.32%
1 Year Est. Return
+87.29%
3 Year Est. Return
+211.84%
5 Year Est. Return
+162.22%
10 Year Est. Return
+656.25%
AUM
$9.8B
AUM Growth
+$1.34B
Cap. Flow
+$1.32B
Cap. Flow %
13.46%
Top 10 Hldgs %
22.18%
Holding
1,749
New
756
Increased
260
Reduced
198
Closed
532

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$299M
2
MSTR icon
Strategy Inc
MSTR
+$174M
3
NOW icon
ServiceNow
NOW
+$152M
4
AMD icon
Advanced Micro Devices
AMD
+$149M
5
TSM icon
TSMC
TSM
+$145M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$282M
2
RY icon
Royal Bank of Canada
RY
+$265M
3
HOOD icon
Robinhood
HOOD
+$258M
4
PLTR icon
Palantir
PLTR
+$194M
5
AAPL icon
Apple
AAPL
+$164M

Sector Composition

Rank Sector Weight
1 Technology 24.12%
2 Consumer Discretionary 12.45%
3 Industrials 11.48%
4 Financials 10.67%
5 Healthcare 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TLX
876
Telix Pharmaceuticals
TLX
$3.99B
$276K ﹤0.01%
+36,828
New +$354K
BALL icon
877
Ball Corp
BALL
$16.6B
$274K ﹤0.01%
+5,172
New +$255K
OGG
878
Osisko Gold Group Inc.
OGG
$832M
$273K ﹤0.01%
+78,201
New +$269K
JJSF icon
879
J&J Snack Foods
JJSF
$1.68B
$272K ﹤0.01%
3,015
+574
+24% +$52K
ARX
880
Accelerant Holdings
ARX
$2.63B
$271K ﹤0.01%
16,563
-54,196
-77% -$763K
EFOR
881
Everforth Inc
EFOR
$1.33B
$270K ﹤0.01%
5,615
-22,718
-80% -$1.05M
QNCX icon
882
Quince Therapeutics
QNCX
$30M
$268K ﹤0.01%
+401
New +$202K
RAPP
883
Rapport Therapeutics
RAPP
$2.25B
$268K ﹤0.01%
+8,837
New +$245K
SUPN icon
884
Supernus Pharmaceuticals
SUPN
$2.74B
$268K ﹤0.01%
+5,385
New +$262K
MAIN icon
885
Main Street Capital
MAIN
$5.44B
$267K ﹤0.01%
+4,425
New +$261K
CTNM
886
Contineum Therapeutics
CTNM
$545M
$267K ﹤0.01%
+23,377
New +$267K
TBLA icon
887
Taboola.com
TBLA
$1.12B
$267K ﹤0.01%
57,957
+18,585
+47% +$70K
BZH icon
888
Beazer Homes USA
BZH
$904M
$264K ﹤0.01%
+13,024
New +$290K
LNTH icon
889
Lantheus
LNTH
$6.59B
$261K ﹤0.01%
+3,924
New +$228K
INSP icon
890
Inspire Medical Systems
INSP
$1.73B
$261K ﹤0.01%
+2,830
New +$271K
EWQ icon
891
iShares MSCI France ETF
EWQ
$334M
$260K ﹤0.01%
+5,768
New +$257K
NEWP
892
New Pacific Metals
NEWP
$1.16B
$259K ﹤0.01%
+73,853
New +$202K
DTIL icon
893
Precision BioSciences
DTIL
$206M
$258K ﹤0.01%
62,129
+48,158
+345% +$273K
RLMD icon
894
Relmada Therapeutics
RLMD
$484M
$258K ﹤0.01%
+53,444
New +$179K
TSBK icon
895
Timberland Bancorp
TSBK
$350M
$258K ﹤0.01%
7,203
+199
+3% +$6.72K
INMD icon
896
InMode
INMD
$873M
$257K ﹤0.01%
+17,519
New +$258K
AVBP icon
897
ArriVent BioPharma
AVBP
$1.44B
$257K ﹤0.01%
+12,763
New +$266K
JBSS icon
898
John B. Sanfilippo & Son
JBSS
$965M
$257K ﹤0.01%
+3,634
New +$247K
PROF
899
Profound Medical
PROF
$267M
$256K ﹤0.01%
+32,574
New +$209K
CCCC icon
900
C4 Therapeutics
CCCC
$400M
$254K ﹤0.01%
+133,112
New +$315K
34 35
36
37 38

Similar funds

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
VA
Vident Advisory Alpharetta, Georgia $11.7B AUM 37.32% 1-Year Est. Return
PI
PineBridge Investments New York $11.9B AUM 23.42% 1-Year Est. Return
UE
Unisphere Establishment Vaduz, Liechtenstein $11.9B AUM 6.1% 1-Year Est. Return
LC
Loews Corp New York $11.9B AUM 8.99% 1-Year Est. Return
DWM
Dynasty Wealth Management St. Petersburg, Florida $11.5B AUM 15.23% 1-Year Est. Return
ERSOT
Employees Retirement System of Texas Austin, Texas $11.4B AUM 21.6% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return

Quadrature Capital's Q4 2025 Portfolio in Review

As of Q4 2025, Quadrature Capital held 1,749 positions worth $9.8B, up 16% from $8.45B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Quadrature Capital deployed $1.32B of net new capital in Q4 2025, opening 756 new positions and adding to 260 existing holdings. Its largest new stake was UnitedHealth: 882,161 shares worth $291M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 27% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Royal Bank of Canada, an estimated $265M trimmed.

  • Quadrature Capital's largest Q4 2025 buy was UnitedHealth: 882,161 shares worth $291M.
  • Quadrature Capital added most to Advanced Micro Devices in Q4 2025, an estimated $149M increase.
  • Quadrature Capital's biggest Q4 2025 reduction was Royal Bank of Canada, cutting an estimated $265M.
  • Quadrature Capital fully exited NVIDIA in Q4 2025, selling an estimated $282M.
  • Quadrature Capital's ten largest holdings make up 22% of its $9.8B portfolio in Q4 2025.
  • Quadrature Capital opened 756 new positions and closed 532 in Q4 2025.
  • Quadrature Capital's portfolio value rose 16% quarter-over-quarter to $9.8B.

Based on Quadrature Capital's 13F filing for Q4 2025, filed 17 Feb 2026.